Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

26

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105427231

Full Text :

https://doi.org/10.1200/JCO.2009.22.0541